#90, Innovations in Biomarker & Diagnostic Development, Part Two of the Health Innovation Compilation Series

Relation leverages single-cell multi-omics, functional assays, and machine learning to better characterize diseases and develop transformational medicines.

Automata's LINQ platform integrates lab instruments, robotics, and cloud software to streamline scientific workflows and accelerate drug discovery research.

Perspectum enables non-invasive "virtual biopsies" that provide safer, more accessible disease monitoring for conditions like liver disease, diabetes, and cancer.

Happiest Baby's SNOO Smart Sleeper is an FDA-approved cradle that tracks baby's sleep, sends alerts, and automatically soothes with womb-like motions.

PhaseV is pioneering the use of reinforcement learning, causal ML, and adaptive trial design to optimize resource utilization and time efficiency in drug development.

MDI Health has developed an innovative AI solution used by payers and value-based providers to optimize medication management, identify high-risk patients, and reduce overall healthcare expenditure.

Ikerian is pioneering the use of non-invasive retinal imaging and AI to identify biomarkers that can predict disease progression and treatment response.

Ibex AI's Galen™ platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers reduce diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity.

Zoundream's solution uses AI to analyze infant cries and sounds in real-time, pinpointing reasons such as hunger or tiredness with remarkable accuracy, and detecting early signs of conditions like autism.

Featuring Mendel, Akrivia Health, Epistemix, Ovation, and Evidation Health, this episode explores how innovative companies are leveraging real-world data and AI to drive precision medicine, uncover new treatments, and improve population health outcomes.